Becoming a Member
OSIC, the Open Source Imaging Consortium – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.
Our mission? To increase the efficiency and effectiveness of ILD research by bringing together the world’s best and brightest radiologists, clinicians, computational scientists, and industry competitors to collaborate on the development of digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.
We work together in pre-competitive areas for mutual benefit and most importantly, the benefit of patients. And we don’t let politics get in the way.
We hope you’ll join us.
When you step into an intersection of fields, disciplines or cultures, you can combine existing concepts into a large number of extraordinary ideas."
The Medici Effect
Access to the OSIC Global Data Repository
Our first-of-its kind, data-rich repository of anonymized HRCT scans and clinical information regarding interstitial lung diseases (ILDs) is on its way to becoming the world’s largest and most diverse, with a plethora of real world clinical and imaging data that is both multi-ethnic and multi-center. Our database has been vetted by two global GDPR/HIPAA privacy firms, has Central IRB and multiple institution IRB approvals, and is managed in compliance with all applicable privacy laws, regulations, consents and related restrictions.
15,000 anonymized scans with accompanying clinical data
Committed to Date:
15,812 anonymized scans with accompanying clinical data
Access to Unparalleled Expertise
OSIC is driven by global experts in pulmonology, radiology and artificial intelligence who collaborate and share learnings on behalf of patients everywhere. Our collective brain power is broad and diverse, and members are encouraged to join one of the OSIC functional and influential Working Groups to tap into this expertise and help advance the organization’s mission.
Access to Open Source Collaboration
Our members work together to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy. The digital biomarkers we develop are open source and ready for integration into medical imaging software, and we will facilitate the commercialization and widespread adoption of these biomarkers into clinical practice. We also facilitate cooperative research efforts throughout the year, including the development and execution of machine learning competitions and collaborations.
Partnerships with Patient Advocacy Groups
Our singular focus has never wavered. The heart of everything we do has always been, and always will be, on the patients. For that reason, OSIC works very closely with patient advocacy groups, including the American Lung Association, EU-IPFF, PF Warriors, Action for Pulmonary Fibrosis, for guidance and patient input in all we do.
These organizations have made multi-year commitments of funding and/or pledged to contribute with imaging, clinical data, or other means to ensure OSIC is positioned for success.